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Protocol
AbstrACt
Introduction Premature infants are particularly 
vulnerable to brain injuries with associated cognitive 
and behavioural deficits. The worldwide first randomised 
interventional multicentre trial investigating the 
neuroprotective effects of erythropoietin (entitled ‘Does 
erythropoietin improve outcome in very preterm infants?’ 
(NCT00413946)) included 450 very preterm infants 
in Switzerland. MRI at term equivalent age showed 
less white matter (WM) injury in the erythropoietin 
group compared with the placebo group. Despite 
these promising imaging findings, neurodevelopmental 
outcome at 2 years showed no beneficial effect of 
early erythropoietin. One explanation could be that the 
assessment of more complex cognitive functions such as 
executive functions (EFs) is only possible at a later age. 
We hypothesise that due to improved WM development 
and fewer WM injuries, children born preterm treated with 
early erythropoietin will have better EF abilities at 7–12 
years than those treated with placebo.
Methods and analysis 365 children who were 
included into the primary analysis of the original trial 
(NCT00413946) will be eligible in this prospective 
follow-up study at the age of 7–12 years. 185 children 
born at term will be control children. Primary outcome 
measures are EF abilities and processing speed, while 
secondary outcomes are academic performance, IQ, 
fine motor abilities and global brain connectivity. A 
comprehensive test battery will be applied to assess EFs. 
MRI will be performed to assess global brain connectivity. 
Cognitive scores and MRI measures will be compared 
between both groups using the Wilcoxon test. Propensity 
score matching will be used to balance gender, age, 
socioeconomic status and other potentially unbalanced 
variables between the children born preterm and the 
healthy control children.
Ethics and dissemination The cantonal ethical 
committee granted ethical approval for this study (KEK 
2017-00521). Written consent will be obtained from the 
parents. Findings from this study will be disseminated via 
international and national conference presentations and 
publications in peer-reviewed journals.
IntroduCtIon
Premature infants are particularly vulnerable 
to brain injury. As a consequence of peri-
natal brain injury, 5%–10% of survivors of 
premature birth develop cerebral palsy, and 
40%–50% develop cognitive and behavioural 
deficits.1 2 A meta-analysis showed that chil-
dren born very preterm manifest moderate 
to severe deficits in academic achievement, 
attention problems, internalising problems 
and poor executive functions.3 Executive 
functions refer to a family of top-down mental 
processes needed to attend to a task requiring 
concentration and attention.4 Three core 
executive functions have been described, 
namely, inhibition (the ability to suppress an 
automatic response), working memory (the 
strengths and limitations of this study
 ► Long-term effects of early high-dose erythropoie-
tin administration on executive function abilities and 
brain development will be investigated in children 
born very preterm.
 ► Long-term follow-up data on executive function 
abilities, processing speed and academic perfor-
mance of a large cohort of very preterm children will 
be available through this study.
 ► Executive function abilities will be assessed com-
prehensively using standardised neuropsychological 
tests to measure core functions such as inhibition, 
cognitive flexibility, working memory and planning, 
and by investigating everyday life abilities as report-
ed by the parents.
 ► Potential recruitment bias by the neurodevelopmen-
tal outcome of children born very preterm and by the 
socioeconomic status exists.
 ► Achieving the desired follow-up rate might prove 
challenging since the original randomised controlled 
trial was conducted between 2005 and 2012.
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ability to manipulate information in short-term memory) 
and cognitive flexibility (the ability to switch between 
different mindsets, creatively thinking ‘outside the box’).5 
Children born very preterm frequently perform worse in 
tests of inhibition, working memory and cognitive flexi-
bility than age-matched term-born controls.3 6 7 Deficits 
across multiple executive function domains were also 
reported in adolescents8 9 and in adults born preterm.10–12 
In addition to deficits in executive functions, processing 
speed has also been shown to be affected in adults born 
preterm.10 This is consistent with studies in children born 
preterm showing slower processing speed than term born 
children in infancy,13 14 toddlerhood15 and middle child-
hood.9 16 17 These impairments are likely to influence 
academic success. Indeed, it has been reported in school-
aged children born very preterm that executive function 
deficits have a strong impact on learning skills9 and that 
processing speed and working memory abilities underlie 
academic attainment.18 19 
Associations between executive function deficits and 
cortical abnormalities have been reported in children 
and adults born very preterm.20–22 Structural alterations 
such as reduced grey and white matter volume accounted 
for 29% of the variance in executive functions in adoles-
cents born very preterm at 12 years of age.23 Also, delayed 
cortical maturational trajectories and significant asso-
ciations between the change in cortical thickness and 
executive function scores were observed in adolescents 
born very preterm.21 Similarly, processing speed appears 
to be related to neonatal brain injury in very preterm 
children.24
The high incidence of neurodevelopmental impair-
ments including executive function deficits in very 
preterm infants is reflected in the ongoing search for 
neuroprotective interventions that can prevent brain 
injury or enhance repair of the immature brain, with 
the ultimate goal of improving long-term motor and 
cognitive outcome.25 However, to date, no such postnatal 
neuroprotective intervention has been implemented 
into clinical management of very preterm infants. A 
neuroprotective intervention ideally addresses both the 
prevention of brain injury and subsequent failure of 
normal brain development.26 Among several pharmaco-
logical candidates to prevent brain injury or to improve 
its development, erythropoietin has been shown to be 
one of  the most promising neuroprotective agents.27 
Erythropoietin may exert its neuroprotective role by 
preventing acute injury via inhibition of glutamate 
release, modulation of intracellular calcium metabo-
lism, induction of neuronal antiapoptotic factors, reduc-
tion of inflammation, decrease of nitric oxide-mediated 
injury and direct antioxidant effects.28 29 Furthermore, 
erythropoietin plays a role in developmental mecha-
nisms, as it promotes proliferation and differentiation of 
preoligodendrocytes, and stimulates growth factors, such 
as vascular endothelial growth factor for increased angio-
genesis, and brain-derived neurotrophic factor required 
for brain growth.28
In Switzerland, the first interventional trial in very 
preterm infants using high-dose erythropoietin as a 
potential neuroprotective agent was initiated in 2005. 
It was a randomised, double-blind placebo-controlled, 
prospective multicentre trial entitled ‘Does erythro-
poietin improve outcome in very preterm infants?’ 
(NCT00413946) and has included 450 very preterm 
infants born below 32 weeks of gestation between 2005 
and 2012.30 Conventional MRI assessed in a subgroup of 
these infants showed that erythropoietin treatment was 
associated with a reduced risk of periventricular white 
matter injury, grey matter injury, white matter signal 
abnormalities and periventricular white matter volume 
loss, with a number needed to treat of seven preterm 
infants.31 Using tract-based spatial statistics of diffusion 
tensor imaging data, it was also shown that early high-
dose erythropoietin improved white matter development 
at term equivalent age in these very preterm infants.32 
Importantly, improvement of white matter development 
was seen globally and was consistent with findings from 
the conventional MRI analysis.31 At 2 years of age, neuro-
developmental outcome data were available for 365 
children (81%). The mean mental and motor develop-
mental indices as assessed by the Bayley Scales of Infant 
and Toddler Development-II were similar in both the 
erythropoietin and the placebo group.30 In light of the 
positive effects of erythropoietin on brain development, 
the question arises why these effects did not translate into 
improved neurodevelopmental outcome at 2 years of age. 
Two possible explanations are that, first, the sample size 
might have been too small. This would be in line with 
the findings of a recent meta-analysis, comprising 1113 
infants of four randomised controlled studies, showing 
that prophylactic erythropoietin improved the cognitive 
development at 18–24 months.33 Second, merely devel-
opmental milestones can be measured at this young age 
while more complex cognitive functions such as execu-
tive functions are only developing,7 and hence the 2-year 
outcome might be used as a proof for safety of neuropro-
tective agents rather than their efficacy.34 We therefore 
speculate that in our cohort of infants, early high-dose 
erythropoietin may produce benefits for cognitive devel-
opment that become apparent only at a later age once 
higher-order cognitive functions develop and potential 
deficits may become evident. We hypothesise that the 
improved white matter development and the reduced 
rate of white matter injuries will be reflected in better 
executive functions and in improved processing speed 
at school age; hence, that early high-dose erythropoietin 
administration after birth will lead to improved execu-
tive functions and processing speed at school age in very 
preterm children.
HypotHEsEs And AIMs of tHIs study
The main aim of this project is to examine whether 
early administration of high-dose erythropoietin in 
very preterm infants has long-term beneficial effects on 
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executive functions, processing speed and global brain 
connectivity.
1. Very preterm children treated with early high-dose 
erythropoietin will have better executive function 
abilities and faster processing speed than those treat-
ed with placebo at the age of 7–12 years.
2. Global brain network connectivity is better in the chil-
dren who were treated with early high-dose erythro-
poietin than in those treated with placebo.
3. There is a continuum in executive function and aca-
demic performance within term born children, chil-
dren born very preterm treated with high-dose eryth-
ropoietin and children born very preterm allocated 
to placebo.
4. Improved longitudinal brain development between 
term equivalent age and 7–12 years (n=165) can be 
shown in those children who were treated with early 
high-dose erythropoietin compared with those treat-
ed with placebo.
MEtHods And AnAlysIs
study participants
Very preterm children who participated in the trial 
entitled ‘Does erythropoietin improve outcome in 
very preterm infants?’ (NCT00413946) will be recruited at 
the age of 7–12 years. A total of 450 infants were enrolled 
and randomised (mean (range) gestational age, 29.0 
(26.0–30.9) weeks; 264 (59%) female; mean (range) birth 
weight, 1210 (490–2290) g). Among them, 230 were allo-
cated to the erythropoietin and 220 to the placebo group. 
Two infants in the erythropoietin group were excluded 
due to diagnosis of syndromes, which affect neurodevel-
opmental outcome (n=448). In the erythropoietin and 
placebo group, 57 infants received erythropoietin either 
in another dose as allocated or received supplemental 
erythropoietin and were therefore excluded. Further, 63 
infants were excluded from the primary analysis (death 
or drop out), leaving 365 infants who were included into 
the primary analysis and therefore eligible for this study: 
191 infants in the erythropoietin and 174 infants in the 
placebo group. A database of the erythropoietin trial 
including perinatal, socioeconomic and follow-up assess-
ment data at 2 and 5 years of age has been established. 
Recruitment of the very preterm children will be done 
with an invitation letter sent by post and thereafter by 
telephone contact. In addition, 185 children born at term 
will be recruited as friends/siblings/peers of the preterm 
children or by advertisement through social media (www. 
epokids. ch) and at schools.
primary and secondary outcome
The primary outcome measures of this study are exec-
utive functions and processing speed. The secondary 
outcome measures include academic performance, intel-
ligence, fine motor abilities, brain development (global 
brain connectivity, network characteristics, brain volumes 
and biochemical profiles) assessed by MRI as well as 
behavioural problems, quality of life and variables of 
the family environment. The comparison of cognitive 
outcome measures and brain development between chil-
dren born at term and children born very preterm is also 
a secondary outcome measure.
Primary outcome measures: executive functions and processing 
speed
Standardised neuropsychological tasks will be used to 
capture key aspects of executive functions, such as inhi-
bition and interference, working memory, cognitive flex-
ibility, planning, fluency and processing speed (table 1). 
Specifically, the stop-signal paradigm is a computerised 
tool for the investigation of response inhibition.35 For this 
study, the task will be implemented in MATLAB (Math-
Works) using the Psychtoolbox extensions.36 All settings 
will be adopted from a previous study with very preterm 
children of a similar age.37 In addition to the different 
measures of response inhibition, the mean reaction time 
of all correct go-trials will be used to assess processing 
speed. The ‘Test Battery for Attention Testing’ (Testbat-
terie zur Aufmerksamkeitsprüfung38) consists of a set of 
computerised tests to selectively assess specific aspects 
of attentional processes. In this study, the flexibility and 
working memory subtests will be administered. The 
‘Delis-Kaplan Executive Function System’39 is a test battery 
designed exclusively for the assessment of executive func-
tions, within both verbal and spatial modalities. For this 
Table 1 Executive function abilities and processing speed
Assessed abilities Applied assessment tools
Inhibition and 
interference
Stop-Signal Task (stop-signal reaction 
time)
Color Word Interference Task (D-KEFS)
Working memory Digit Span forward/backward (WISC-
IV)
Corsi Block Tapping Test
TAP Working Memory (TAP 2.3)
Cognitive flexibility Trail Making Task (D-KEFS)
TAP Flexibility (TAP 2.3)
Planning Tower Task (D-KEFS)
Fluency Verbal Fluency (RWT)
Design Fluency (D-KEFS)
Executive functions 
in everyday life
Parent rating (BRIEF questionnaire)
Processing speed Coding, Symbol Search (both WISC-
IV)
Stop-Signal Task (mean reaction time 
of correct go trials)
Study-specific test battery to assess executive functions and 
processing speed.
BRIEF, Behaviour Rating Inventory of Executive Functions; 
D-KEFS, Delis-Kaplan Executive Function System; RWT, 
Regensburger Verbal Fluency Test (Regensburger 
Wortflüssigkeitstest); TAP, Test Battery for Attention Testing 
(Testbatterie zur Aufmerksamkeitsprüfung); WISC-IV, 
Wechsler Intelligence Scale for Children Fourth Edition. 
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study, the Color-Word-Interference Task (inhibition), 
the Trail Making Task (cognitive flexibility), the Tower 
Task (visual-spatial planning) and the Design Fluency 
Test (fluency in generating visual patterns) will be used. 
The ‘Regensburger Verbal Fluency Test’ (Regensburger 
Wortflüssigkeitstest40) is a German language verbal 
fluency test, and phonetic and semantic subtests will be 
used for this study. The ‘Corsi Block Tapping-Test’41 is a 
well-validated tool often applied in clinical practice and 
experimental research. The forward and backward condi-
tions will be used to assess visual-spatial short-term and 
working memory, respectively. The following subtests of 
the ‘Wechsler Intelligence Scale for Children, Fourth 
Edition’ (WISC-IV, German version42) will be used: the 
Digit Span subtest will be used to assess verbal short-
term, and working memory and the Symbol Search and 
Coding subtests will be used to assess processing speed. 
The ‘Behaviour Rating Inventory of Executive Functions’ 
(BRIEF43) is a questionnaire designed to gather infor-
mation about an individual’s use of executive function 
skills in daily life (at home and in school). Parents will 
complete this questionnaire.
Secondary outcome measures
Intelligence, fine motor abilities and academic performance
Intelligence will be estimated with four subtests of the 
WISC-IV42: Block Design, Similarities, Digit Span and 
Coding. This subtest combination has been shown to 
correlate highly with the full version (r>0.90).44 To 
assess fine motor abilities, the Pegboard and Sequential 
Finger Movements subtests of the Zurich Neuromotor 
Assessment45 will be used. Due to the lack of a compre-
hensive test battery to assess academic abilities appro-
priate for the Swiss school system (such as for example 
the Wechsler Individual Achievement Test-II46), in this 
study, subtests of different validated instruments will 
be applied to assess math, reading and spelling skills: 
mathematical abilities will be tested with the Subtrac-
tion and Completion subtests of the ‘Heidelberger 
Computing Test’ (Heidelberger Rechentest)47 and the 
Applied Math subtest of the ‘Adaptive Intelligence Diag-
nostic Tool’, Third Edition (Adaptives Intelligenzdi-
agnostikum (AID-3)).48 Reading skills will be tested 
with the 1-min Reading Fluency subtest of the ‘Salz-
burger Reading and Writing Test-II’ (Salzburger Lese-/
Rechtschreibtest-II)49 and the Text Comprehension 
subtest of the ‘Salzburger Reading Screening’ (Salz-
burger Lesescreening50). Spelling skills will be tested 
with the Spelling subtest of the ‘Hamburger Writing 
Test’ (Hamburger Schreibprobe51).
This test battery will be divided into two sessions: the 
first testing session will be done in the morning (approx-
imately 2 hours) and the second half (approximately 
1.5−2 hours) after a lunch break, followed by the MRI 
at the end of the day. The executive function tests and 
the tests to assess school skills will be undertaken in a 
randomised order to avoid fatigue effects.
Questionnaires
In addition to collecting cognitive and neuroimaging 
data from the participants, they will also complete two 
questionnaires to report on their quality of life and their 
relationship with their parents. The parents will be asked 
to complete a set of questionnaires to provide detailed 
information on aspects of their children’s behaviour and 
quality of life and on their own health and well-being, 
their relationship with their child and various aspects of 
the family situation. Table 2 provides an overview of the 
applied questionnaires.
Magnetic resonance imaging
Cerebral MRI will be performed on a 3T GE MR750 scanner. 
Hearing protection will be provided with earplugs and 
headsets. The heart and respiratory rate will be monitored 
continuously. Image analysis will focus on group differences 
in the global network connectivity, topology and brain devel-
opment. For this purpose, diffusion tensor imaging will be 
performed (TE/TR=77/6500 ms, 35 gradient sampling 
directions, 4 B0 images, field of view (FOV): 27.8 cm, acqui-
sition matrix: 96×96). Furthermore, for volumetric analysis 
3D T1 SPGR (TE/TR=5/11 ms, inversion time (TI)=600 ms, 
flip angle: 8°, FOV=25.6 cm, reconstruction matrix: 256×256, 
158 slices/slab) and 3D T2 CUBE (TE/TR=98/2800 ms, 
FOV=256 cm, matrix: 256×256) sequences will be acquired. 
Resting-state functional MRI (TE/TR=32/1925 ms, flip 
angle=74°, FOV=27.8 cm, matrix=64×64) will be acquired for 
analysing the functional connectivity between the groups. 
Magnetic resonance spectroscopy (TE/TR 35/3000 ms) will 
be acquired with voxels placed in basal ganglia/thalami and 
frontal white matter, respectively, to look at group differences 
in the biochemical profile. Furthermore, T2 relaxometry will 
be performed using a dual echo PD/T2 FSE sequence (TE1/
TE2/TR=30/118/7000 ms, echo train length=16, FOV=27.8, 
matrix=412×224 (interpolated to 512×512)) in order to look 
at group differences in T2 times in the grey and white matter. 
Longitudinal brain growth can be analysed in the subgroup 
of infants in which imaging was acquired at term equivalent 
age (n=165).31
Comparison of cognitive measures and global brain connectivity 
between children born at term and children born very preterm
Cognitive scores and measures of global brain network 
connectivity will be compared between the children born 
very preterm and those born at term to test whether there 
is a continuum in executive function performance and 
connectivity within term born children, children born very 
preterm treated with early high-dose erythropoietin and 
children born very preterm treated with placebo (see the 
Statistics section).
study design and power calculation
Study design
This is a prospective follow-up project of the randomised 
erythropoietin trial NCT00413946. Recruitment process: 450 
very preterm infants were randomised into the erythropoi-
etin trial between 2005 and 2012. Of these, the 365 children 
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who were included into the primary analysis are eligible and 
will be contacted for this follow-up study. These children will 
be between 7 and 12 years old during the project time and 
are, hence, eligible for this study.
Power calculation: The primary outcome of this study will 
be assessed by the executive function tasks described above. 
Based on the literature, we expect a minimal effect size of 
0.36 (since effect sizes for executive outcome measures range 
from 0.36 for working memory, 0.49 for cognitive flexibility 
and 0.57 for verbal fluency3 when comparing very preterm 
to term-born children). Considering the smallest effect size 
of 0.36, a minimal sample size of 123 children/participants 
per group is required, assuming a two-sided alpha error of 
0.05 and a power (1−beta) of 0.8. To compensate for drop-
outs and considering that the effect size between preterm 
groups (erythropoietin vs placebo) might be smaller than 
between preterm participants and their term-born peers, 
we will add 20% to each group, targeting at least 148 chil-
dren/participants per group, in total 296 children. There 
might be some imbalance in the distribution of gestational 
age, socioeconomic status or gender in the children willing 
to participate in this follow-up study between treatment 
groups. These imbalances will be taken into account in the 
analysis.
Statistics
Descriptive statistics include mean and SD or median 
and IQR for the continuous or ordinally scaled variables. 
Numbers and percentages of total will be reported for 
the categorical variables. Unpaired Wilcoxon tests or 
Table 2 List of applied questionnaires
Assessed domains and subdomains Questionnaire Completed by*
Information on child
  Information on health and academic outcome Detailed information on schooling, health concerns 
and leisure activities
Parents
  Behavioural screening: emotional symptoms, 
conduct problems, hyperactivity/inattention, peer 
relationship problems, prosocial behaviour
Strength and Difficulty Questionnaire55 Parents
  Autistic traits screening Social and Communication Disorder Checklist56 Parents
  Health-related quality of life: physical, psychological 
well-being, autonomy and parent relation, peers and 
social support, school environment
Kidscreen-2757 Parents and 
children
Information on parents
  Executive function abilities relevant for everyday life: 
inhibit, shift, emotional control, self-monitor, initiate, 
working memory, plan/organise, task monitor and 
organisation of materials
Behaviour Rating Inventory of Executive Functions-
Adult version58
Parents
  Physical and mental health: vitality, physical 
functioning, bodily pain, general health perceptions, 
physical role functioning, emotional role functioning, 
social role functioning, mental health
Short Form Health Survey59 Parents
Information on family
  Family socioeconomic status Detailed information on for example, parental age, 
nationality, marital status, first language, maternal 
and paternal education and occupation, current 
living arrangements and financial situation
Parents
  Quality of family environment: family cohesion, 
expressiveness, conflict
Family Relationship Index60 Parents
  Perceived social support for the family Social Support Questionnaire (F-SozU-14)61 Parents
  Parenting: positive parenting behaviour, involvement, 
(poor) monitoring, inconsistent discipline, 
authoritarian parenting, responsible parenting, 
corporal punishment
German version of the Alabama parenting 
Questionnaire for elementary school children 
(DEAPQ-EL-GS)62
Parents
  Quality of parent–child interaction: cohesion, 
identification, autonomy, conflicts, rejection/neglect, 
punishment, emotional burden, fears/overprotection, 
aid
Parental-Representation-Screening-Questionnaire 
(Elternbild-Fragebogen, EBF-KJ)63
Children
  Critical life events 12-item list of critical life events Parents
*Questionnaires are completed by at least one parent.  on
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t-tests for ordinally scaled or continuous variables and χ2 
or Fisher’s exact test for dichotomous outcomes will be 
used. Linear regression models will be used to examine 
differences between the groups in executive function 
abilities. The independent variable in all regression 
models will be group status (erythropoietin vs placebo) 
and potentially other variables such as gender, gesta-
tional age and socioeconomic status. P values <0.05 will 
be considered statistically significant. Brain network 
features will be analysed using graph theory measures, 
characterising network structure and function.52 53 
Network description will include measures of topolog-
ical organisation (modularity, small-world and rich-club 
indices), integration and segregation. Cognitive scores 
and measures of global brain network connectivity and 
topography will be compared between the erythropoi-
etin and placebo group using the Wilcoxon test. The 
statistical programming language R54 for Windows will 
be used for all analyses.
In a secondary analysis, the 185 term-born control chil-
dren, primarily recruited for the evaluation in this study, 
will be compared with the children born very preterm 
included in the erythropoietin trial. Propensity score 
matching will be used to balance gender, age, socioeco-
nomic status and other potentially unbalanced variables 
between the children born very preterm and the term-
born control children. The aim of this approach is to 
balance other factors, enabling the quantification of the 
effects of being born very preterm, and within subgroups 
of children with or without erythropoietin.
EtHICs And dIssEMInAtIon
 Written informed consent will be obtained from the 
parents. Data handling, record keeping and archiving 
will be done according the guidelines given by the ethical 
committee. The results of this study will be published in 
peer-reviewed journals, and the findings will be presented 
at national and international conferences for widespread 
dissemination of the results.
Author affiliations
1Department of Neonatology and Pediatric Intensive Care, University Children’s 
Hospital Zurich, Zurich, Switzerland
2Children’s Research Center, University Children’s Hospital Zurich, Zurich, 
Switzerland
3Child Development Center, University Children’s Hospital Zurich, Zurich, 
Switzerland
4Department Biostatistics, Epidemiology, Biostatistics and Prevention Institute, 
University of Zurich, Zurich, Switzerland
5MR Research Centre, University Children’s Hospital Zurich, Zurich, Switzerland
6Department of Neonatology, University Hospital Zurich and University of Zurich, 
Zurich, Switzerland
7Division of Child Development and Growth, Department of Paediatrics, Geneva 
University, Geneva, Switzerland
Contributors CFH, FW, RTOG, UH and BL were involved in the study design. FW, 
BS, VD and CFH were responsible for conceiving ethical approval. CFH, FW, RTOG 
and UH wrote the first draft of the manuscript. CFH, FW, RTOG, UH, BL, PH, J-CF, VD 
and BS commented and critically reviewed drafts of the paper.
funding This project is supported by the Swiss National Science Foundation (grant 
number 320030_169733), the Gottfried and Julia Bangerter-Rhyner Foundation, the 
Hartmann Müller Foundation and the Uniscientia Foundation. 
Competing interests None declared.
patient consent Parental/guardian consent obtained.
Ethics approval The cantonal ethical committee of Zurich, Switzerland, granted 
ethical approval for this study in May 2017 (KEK 2017-00521). 
provenance and peer review Not commissioned; peer reviewed for ethical and 
funding approval prior to submission.
open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
rEfErEnCEs
 1. Lacey DJ, Topper WH, Buckwald S, et al. Preterm very-low-birth-
weight neonates: relationship of EEG to intracranial hemorrhage, 
perinatal complications, and developmental outcome. Neurology 
1986;36:1084–7.
 2. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm 
birth from infancy to adulthood. Lancet 2008;371:261–9.
 3. Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, et 
al. Meta-analysis of neurobehavioral outcomes in very preterm and/
or very low birth weight children. Pediatrics 2009;124:717–28.
 4. Miller P, Brody CD, Romo R, et al. A recurrent network model of 
somatosensory parametric working memory in the prefrontal cortex. 
Cereb Cortex 2003;13:1208–18.
 5. Diamond A. Executive functions. Annu Rev Psychol 2013;64:135–68.
 6. Johnson S, Wolke D, Hennessy E, et al. Educational outcomes 
in extremely preterm children: neuropsychological correlates and 
predictors of attainment. Dev Neuropsychol 2011;36:74–95.
 7. Anderson P. Assessment and development of executive function (EF) 
during childhood. Child Neuropsychol 2002;8:71–82.
 8. Burnett AC, Scratch SE, Lee KJ, et al. Executive function in 
adolescents born <1000 g or <28 weeks: a prospective cohort study. 
Pediatrics 2015;135:e826–34.
 9. Farooqi A, Adamsson M, Serenius F, et al. Executive functioning and 
learning skills of adolescent children born at fewer than 26 weeks of 
gestation. PLoS One 2016;11:e0151819.
 10. Nosarti C, Giouroukou E, Micali N, et al. Impaired executive 
functioning in young adults born very preterm. J Int Neuropsychol 
Soc 2007;13:571–81.
 11. Pyhälä R, Lahti J, Heinonen K, et al. Neurocognitive abilities in young 
adults with very low birth weight. Neurology 2011;77:2052–60.
 12. Eryigit Madzwamuse S, Baumann N, Jaekel J, et al. Neuro-cognitive 
performance of very preterm or very low birth weight adults at 26 
years. J Child Psychol Psychiatry 2015;56:857–64.
 13. Rose SA, Feldman JF, Jankowski JJ, et al. Pathways from 
prematurity and infant abilities to later cognition. Child Dev 
2005;76:1172–84.
 14. Rose SA, Feldman JF, Jankowski JJ, et al. A cognitive cascade in 
infancy: pathways from prematurity to later mental development. 
Intelligence 2008;36:367–78.
 15. Rose SA, Feldman JF, Jankowski JJ. Information processing in 
toddlers: continuity from infancy and persistence of preterm deficits. 
Intelligence 2009;37:311–20.
 16. Rose SA, Feldman JF. Memory and processing speed in preterm 
children at eleven years: a comparison with full-terms. Child Dev 
1996;67:2005–21.
 17. Mulder H, Pitchford NJ, Marlow N. Processing speed mediates 
executive function difficulties in very preterm children in middle 
childhood. J Int Neuropsychol Soc 2011;17:445–54.
 18. Mulder H, Pitchford NJ, Marlow N. Processing speed and working 
memory underlie academic attainment in very preterm children. Arch 
Dis Child Fetal Neonatal Ed 2010;95:F267–72.
 19. Rose SA, Feldman JF, Jankowski JJ. Modeling a cascade of effects: 
the role of speed and executive functioning in preterm/full-term 
differences in academic achievement. Dev Sci 2011;14:1161–75.
 o
n
 10 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022157 on 24 April 2018. Downloaded from 
7Wehrle FM, et al. BMJ Open 2018;8:e022157. doi:10.1136/bmjopen-2018-022157
Open Access
 20. Skranes J, Løhaugen GC, Evensen KA, et al. Entorhinal cortical 
thinning affects perceptual and cognitive functions in adolescents 
born preterm with very low birth weight (VLBW). Early Hum Dev 
2012;88:103–9.
 21. Nam KW, Castellanos N, Simmons A, et al. Alterations in cortical 
thickness development in preterm-born individuals: Implications for 
high-order cognitive functions. Neuroimage 2015;115:64–75.
 22. Bjuland KJ, Løhaugen GC, Martinussen M, et al. Cortical thickness 
and cognition in very-low-birth-weight late teenagers. Early Hum Dev 
2013;89:371–80.
 23. Nosarti C, Giouroukou E, Healy E, et al. Grey and white 
matter distribution in very preterm adolescents mediates 
neurodevelopmental outcome. Brain 2008;131:205–17.
 24. Murray AL, Scratch SE, Thompson DK, et al. Neonatal brain 
pathology predicts adverse attention and processing speed 
outcomes in very preterm and/or very low birth weight children. 
Neuropsychology 2014;28:552–62.
 25. Gonzalez FF, Abel R, Almli CR, et al. Erythropoietin sustains cognitive 
function and brain volume after neonatal stroke. Dev Neurosci 
2009;31:403–11.
 26. Volpe JJ. Brain injury in premature infants: a complex amalgam 
of destructive and developmental disturbances. Lancet Neurol 
2009;8:110–24.
 27. Robertson NJ, Tan S, Groenendaal F, et al. Which neuroprotective 
agents are ready for bench to bedside translation in the newborn 
infant? J Pediatr 2012;160:544–52.
 28. Juul S. Neuroprotective role of erythropoietin in neonates. J Matern 
Fetal Neonatal Med 2012;25(Suppl 4):105–7.
 29. Shingo T, Sorokan ST, Shimazaki T, et al. Erythropoietin regulates 
the in vitro and in vivo production of neuronal progenitors 
by mammalian forebrain neural stem cells. J Neurosci 
2001;21:9733–43.
 30. Natalucci G, Latal B, Koller B, et al. Effect of early prophylactic high-
dose recombinant human erythropoietin in very preterm infants on 
neurodevelopmental outcome at 2 years: a randomized clinical trial. 
JAMA 2016;315:2079–85.
 31. Leuchter RH, Gui L, Poncet A, et al. Association between early 
administration of high-dose erythropoietin in preterm infants 
and brain MRI abnormality at term-equivalent age. JAMA 
2014;312:817–24.
 32. O'Gorman RL, Bucher HU, Held U, et al. Tract-based spatial 
statistics to assess the neuroprotective effect of early erythropoietin 
on white matter development in preterm infants. Brain 
2015;138:388–97.
 33. Fischer HS, Reibel NJ, Bührer C, et al. Prophylactic early 
erythropoietin for neuroprotection in preterm infants: a meta-analysis. 
Pediatrics 2017;139:e20164317.
 34. Marlow N. Is survival and neurodevelopmental impairment at 2 years 
of age the gold standard outcome for neonatal studies? Arch Dis 
Child Fetal Neonatal Ed 2015;100:F82–4.
 35. Verbruggen F, Logan GD. Response inhibition in the stop-signal 
paradigm. Trends Cogn Sci 2008;12:418–24.
 36. Brainard DH. The Psychophysics Toolbox. Spat Vis 1997;10:433–6.
 37. Aarnoudse-Moens CS, Duivenvoorden HJ, Weisglas-Kuperus N, et 
al. The profile of executive function in very preterm children at 4 to 12 
years. Dev Med Child Neurol 2012;54:247–53.
 38. Zimmermann P, Fimm B. TAP; Testbatterie zur 
Aufmerksamkeitspruefung; Testbattery for Attentional Performance. 
Herzogenrath, Germany: Psytest, 1993.
 39. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function 
system (D-KEFS): Psychological Corporation, 2001.
 40. Aschenbrenner S, Tucha O, Lange KW. Regensburger 
Wortflüssigkeits-Test (RWT) [Regensburger verbal fluency test (RWT)]. 
Göttingen: Hogrefe Verlag, 2000.
 41. Kessels RP, van Zandvoort MJ, Postma A, et al. The corsi block-
tapping task: standardization and normative data. Appl Neuropsychol 
2000;7:252–8.
 42. Petermann F, Petermann U. Hamburg-Wechsler Intelligenztest für 
Kinder-IV (HAWIK-IV) [Hamburg-Wechsler-Intelligence Test for 
children (HAWIK-IV)]. Bern: Huber, 2006.
 43. Drechsler R, Steinhausen H-C. BRIEF: Verhaltensinventar zur 
Beurteilung exekutiver Funktionen. Manual. [BRIEF. A behavioral 
inventory to assess executive functions. Manual]. Bern, Switzerland: 
Huber, 2013.
 44. Waldmann H-C. Kurzformen des HAWIK-IV: Statistische Bewertung 
in verschiedenen Anwendungsszenarien [German WISC-IV short 
forms: a scenario-based evaluation of statistical properties]. 
Diagnostica 2008;54:202–10.
 45. Largo RH. Zurich Neuromotor Assessment. Zurich: AWE Verlag, 
2007.
 46. Wechsler D. Wechsler Individual Achievement Test-II. Antonio: TX: 
The Psychological Corporation, Harcourt Brace & Co, 2001a.
 47. Haffner J. Heidelberger Rechentest (HRT 1-4). Göttingen: Hofgrefe, 
2005.
 48. Kubinger KD, Holocher-Ertl S. Adaptives Intelligenz Diagnostikum 3. 
Göttingen: Beltz Test Gesellschaft, 2014.
 49. Moll K, Landerl K. SLRT-II: Lese-und Rechtschreibtest; 
Weiterentwicklung des Salzburger Lese-und Rechtschreibtests 
(SLRT): Huber, 2010.
 50. Mayringer H, Wimmer H. Salzburger Lese-Screening für die 
Klassenstufen 1-4. Bern, Switzerland: Huber, 2003.
 51. May P. HSP 1–10. Hamburger Schreib-Probe. Göttingen: Hofgrefe, 
2012.
 52. Hagmann P, Grant PE, Fair DA. MR connectomics: a conceptual 
framework for studying the developing brain. Front Syst Neurosci 
2012;6:43.
 53. Fischi-Gómez E, Vasung L, Meskaldji DE, et al. Structural brain 
connectivity in school-age preterm infants provides evidence for 
impaired networks relevant for higher order cognitive skills and social 
cognition. Cereb Cortex 2015;25:2793–805.
 54. R Development Core Team. R: a language and environment for 
statistical computing: R Foundation for Statistical Computing, 2008.
 55. Goodman R. Psychometric properties of the strengths and 
difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 
2001;40:1337–45.
 56. Skuse DH, Mandy WP, Scourfield J. Measuring autistic traits: 
heritability, reliability and validity of the Social and Communication 
Disorders Checklist. Br J Psychiatry 2005;187:568–72.
 57. Ravens-Sieberer U, Auquier P, Erhart M, et al. The KIDSCREEN-27 
quality of life measure for children and adolescents: psychometric 
results from a cross-cultural survey in 13 European countries. Qual 
Life Res 2007;16:1347–56.
 58. Roth RM, Gioia GA. Behavior rating inventory of executive function-
adult version. Lutz, FL: Psychological Assessment Resources, 2005.
 59. Morfeld M, Kirchberger I, Bullinger M. SF-36 Fragebogen zum 
Gesundheitszustand: Deutsche Version des Short Form-36 Health 
Survey: Hogrefe, 2011.
 60. RH M, BS M. Family environment scale manual: Consulting 
Psychologists Press, 1994.
 61. Fydrich T, et al. Fragebogen zur sozialen unterstützung (F-SozU): 
Normierung der Kurzform (K-14). Zeitschrift für Medizinische 
Psychologie 2009;18:43–8.
 62. Reichle B, Franiek S. Erziehungsstil aus elternsicht: Deutsche 
erweiterte version des Alabama Parenting Questionnaire 
für Grundschulkinder (DEAPQ-EL-GS). Zeitschrift für 
Entwicklungspsychologie und Pädagogische Psychologie 
2009;41:12–25.
 63. Titze K, Lehmkuhl U. Elternbildfragebogen für Kinder und 
Jugendliche: EBF-KJ; Manual: Hogrefe, 2010.
 o
n
 10 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022157 on 24 April 2018. Downloaded from 
